Disease Burden and Costs Associated with Multiple Sclerosis in China: A Cross-sectional Analysis of Nationwide Survey Data

Overview

Journal Neurosci Bull

Specialty Neurology

Date 2023 Nov 2

PMID 37917312

Authors

Yusheng Jia

Xuanqi Qiao

Jin Zhao

Hainan Li

Shanlian Hu

Min Hu

Affiliations

Soon will be listed here.

References

Cotsapas C, Mitrovic M, Hafler D . Multiple sclerosis. Handb Clin Neurol. 2018; 148:723-730. DOI: 10.1016/B978-0-444-64076-5.00046-6. View

Min R, Zhang X, Fang P, Wang B, Wang H . Health service security of patients with 8 certain rare diseases: evidence from China's national system for health service utilization of patients with healthcare insurance. Orphanet J Rare Dis. 2019; 14(1):204. PMC: 6700821. DOI: 10.1186/s13023-019-1165-7. View

Guojun T, Yan X, Weizhi W, Lihua W, Chunyang L, Xinghu Z . A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China. Mult Scler Relat Disord. 2022; 60:103732. DOI: 10.1016/j.msard.2022.103732. View

Jones E, Pike J, Marshall T, Ye X . Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US. BMC Health Serv Res. 2016; 16:294. PMC: 4957342. DOI: 10.1186/s12913-016-1532-1. View

Thompson A, Kobelt G, Berg J, Capsa D, Eriksson J, Miller D . New insights into the burden and costs of multiple sclerosis in Europe: Results for the United Kingdom. Mult Scler. 2017; 23(2_suppl):204-216. DOI: 10.1177/1352458517708687. View

Garcia-Dominguez J, Maurino J, Martinez-Gines M, Carmona O, Caminero A, Medrano N . Economic burden of multiple sclerosis in a population with low physical disability. BMC Public Health. 2019; 19(1):609. PMC: 6528334. DOI: 10.1186/s12889-019-6907-x. View

Kurtzke J . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33(11):1444-52. DOI: 10.1212/wnl.33.11.1444. View

Svendsen B, Grytten N, Bo L, Aarseth H, Smedal T, Myhr K . The economic impact of multiple sclerosis to the patients and their families in Norway. Eur J Health Econ. 2018; 19(9):1243-1257. DOI: 10.1007/s10198-018-0971-5. View

Ness N, Schriefer D, Haase R, Ettle B, Cornelissen C, Ziemssen T . Differentiating societal costs of disability worsening in multiple sclerosis. J Neurol. 2019; 267(4):1035-1042. DOI: 10.1007/s00415-019-09676-4. View

10.

. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(3):269-285. PMC: 6372756. DOI: 10.1016/S1474-4422(18)30443-5. View

11.

Tian D, Zhang C, Yuan M, Yang X, Gu H, Li Z . Incidence of multiple sclerosis in China: A nationwide hospital-based study. Lancet Reg Health West Pac. 2021; 1:100010. PMC: 8315658. DOI: 10.1016/j.lanwpc.2020.100010. View

12.

Sand I . The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence. Curr Nutr Rep. 2018; 7(3):150-160. PMC: 6132382. DOI: 10.1007/s13668-018-0236-z. View

13.

Du Y, Min R, Zhang X, Fang P . Factors associated with the healthcare expenditures of patients with multiple sclerosis in urban areas of China estimated by a generalized estimating equation. Expert Rev Pharmacoecon Outcomes Res. 2020; 21(1):137-144. DOI: 10.1080/14737167.2020.1722103. View

14.

Nicholas J, Electricwala B, Lee L, Johnson K . Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data. BMC Neurol. 2019; 19(1):258. PMC: 6816180. DOI: 10.1186/s12883-019-1495-z. View

15.

Xu L, Chen L, Wang S, Feng J, Liu L, Liu G . Urban prevalence of multiple sclerosis in China: A population-based study in six provinces. Eur J Neurol. 2021; 28(5):1636-1644. DOI: 10.1111/ene.14764. View